Last update 17 Apr 2025

FFP-104

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
FFP 104, FFP104, FFP104-001
Target
CD40
Action
inhibitors
Mechanism
CD40 inhibitors(Tumor necrosis factor receptor superfamily member 5 inhibitors)
Therapeutic Areas
Immune System DiseasesDigestive System DisordersOther Diseases
Active Indication-
Inactive Indication
Crohn DiseasePrimary Biliary Cholangitis
Originator Organization
Fast Forward Pharmaceuticals BVFast Forward Pharmaceuticals BV
Active Organization-
Inactive Organization
Fast Forward Pharmaceuticals BVFast Forward Pharmaceuticals BV
Drug Highest PhasePendingPhase 1/2
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Related

2
Clinical Trials associated with FFP-104
NCT02465944
/ Unknown statusPhase 1/2
A Phase II, Double-blind, Randomised, Placebo-controlled, Parallel Group Pilot Study to Evaluate the Safety and Efficacy of FFP104 in the Treatment of Subjects With Moderate to Severely Active Crohn's Disease
NCT02193360
/ Unknown statusPhase 1/2
A Phase I/II, Open Label, Multicenter, Pilot Dose Escalation Study to Evaluate the Safety, Tolerability and Pharmacodynamics of FFP104 in Subjects Previously Diagnosed With Primary Biliary Cirrhosis (PBC)
100 Clinical Results associated with FFP-104
Login to view more data
100 Translational Medicine associated with FFP-104
Login to view more data
100 Patents (Medical) associated with FFP-104
Login to view more data
100 Deals associated with FFP-104
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Crohn DiseasePhase 2
Belgium
Fast Forward Pharmaceuticals BVFast Forward Pharmaceuticals BV
01 Jan 2016
Crohn DiseasePhase 2
Netherlands
Fast Forward Pharmaceuticals BVFast Forward Pharmaceuticals BV
01 Jan 2016
Primary Biliary CholangitisPhase 2
Netherlands
Fast Forward Pharmaceuticals BVFast Forward Pharmaceuticals BV
01 May 2015
Primary Biliary CholangitisPhase 2
United Kingdom
Fast Forward Pharmaceuticals BVFast Forward Pharmaceuticals BV
01 May 2015
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free